Literature DB >> 8613259

Aging progressively impairs endothelium-dependent vasodilation in forearm resistance vessels of humans.

M Gerhard1, M A Roddy, S J Creager, M A Creager.   

Abstract

Studies in experimental models suggest that endothelium-derived nitric oxide is reduced with aging, and this circumstance may be relevant to atherogenesis. The aim of this study was to determine whether increasing age resulted in altered endothelium-dependent vasodilation in the forearm resistance vessels of healthy humans. Forearm blood flow was measured in 119 healthy subjects, aged 19 to 69 years, by venous occlusion plethysmography. Brachial artery infusions of methacholine chloride (0.03 to 10.0 microgram/min) were used to assess endothelium-dependent vasodilation and of sodium nitroprusside (0.03 to 10.0 microgram/min) to assess endothelium-independent vasodilation. The slope of the dose-blood flow response relation was calculated in each subject for each drug. Univariate and multiple stepwise regression analyses were used to relate vascular reactivity to selected variables, including age, lipids, and blood pressure. Endothelium-dependent vasodilation was progressively impaired with increasing age, assessed as a reduction in slope from 2.25 +/- 0.16 to 0.34 +/- 0.11 (mL/100 mL tissue per minute)/(microgram/min) (P <.001). The decline in endothelium-dependent vasodilation was already evident by the fourth decade (age 30 to 39 years). Endothelium-independent vasodilation did not change with age. Age, total cholesterol, and low-density lipoprotein cholesterol were univariate predictors of endothelium-dependent vasodilation. Age remained the most significant predictor of endothelium-dependent vasodilator responses by multiple stepwise regression analysis. From these observations, it can be concluded that endothelium-dependent vasodilation declines steadily with increasing age in healthy human subjects. Age is a strong univariate and multivariate predictor of endothelium-dependent vasodilation. This finding may be a marker for more widespread endothelial dysfunction.

Entities:  

Mesh:

Year:  1996        PMID: 8613259     DOI: 10.1161/01.hyp.27.4.849

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  108 in total

Review 1.  Lipids and endothelium-dependent vasodilation--a review.

Authors:  Lars Lind
Journal:  Lipids       Date:  2002-01       Impact factor: 1.880

Review 2.  Age-related endothelial dysfunction : potential implications for pharmacotherapy.

Authors:  Rachel L Matz; Ramaroson Andriantsitohaina
Journal:  Drugs Aging       Date:  2003       Impact factor: 3.923

Review 3.  The cardiovascular system.

Authors:  A Moore; A A Mangoni; D Lyons; S H D Jackson
Journal:  Br J Clin Pharmacol       Date:  2003-09       Impact factor: 4.335

Review 4.  Exercise and the nitric oxide vasodilator system.

Authors:  Andrew Maiorana; Gerard O'Driscoll; Roger Taylor; Daniel Green
Journal:  Sports Med       Date:  2003       Impact factor: 11.136

5.  Nonlinear dynamics of cardiovascular ageing.

Authors:  Y Shiogai; A Stefanovska; P V E McClintock
Journal:  Phys Rep       Date:  2010-03       Impact factor: 25.600

6.  Influence of age, sex, and aerobic capacity on forearm and skin blood flow and vascular conductance.

Authors:  Gary J Hodges; Lisa Sharp; Richard E Clements; David F Goldspink; Keith P George; Nigel T Cable
Journal:  Eur J Appl Physiol       Date:  2010-03-31       Impact factor: 3.078

Review 7.  Endothelial dysfunction in human diabetes.

Authors:  Sari Mäkimattila; Hannele Yki-Järvinen
Journal:  Curr Diab Rep       Date:  2002-02       Impact factor: 4.810

Review 8.  Functional Nitric Oxide Nutrition to Combat Cardiovascular Disease.

Authors:  Nathan S Bryan
Journal:  Curr Atheroscler Rep       Date:  2018-03-17       Impact factor: 5.113

9.  ETB receptor contribution to vascular dysfunction in postmenopausal women.

Authors:  Megan M Wenner; Kelly N Sebzda; Andrew V Kuczmarski; Ryan T Pohlig; David G Edwards
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2017-04-24       Impact factor: 3.619

Review 10.  Endothelial nitric oxide synthase polymorphisms and hypertension.

Authors:  Aroon D Hingorani
Journal:  Curr Hypertens Rep       Date:  2003-02       Impact factor: 5.369

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.